Joseph C. Gathe
Infectious Disease
4900 Fannin St
Houston, TX 77004
Houston, TX 77004
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 29, 2024
Efficacy and Safety of 2 Fixed Doses of Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced HIV-Positive Individuals.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 17, 2024
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings.
Journal: Frontiers in immunology
Published: January 12, 2024
COVID-19 Coexisting With the Human Immunodeficiency Virus: A Case Report.
Journal: Cureus
Published: November 20, 2020
Efficacy, Pharmacokinetics, and Safety Over 48 Weeks With Ibalizumab-Based Therapy in Treatment-Experienced Adults Infected With HIV-1: A Phase 2a Study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 13, 2020
Human Immunodeficiency Virus in the State of Texas of the United States: Past Reflections, Present Shortcomings, and Future Needs of the Public Health Response.
Journal: Open forum infectious diseases
Published: April 24, 2020
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 05, 2019
Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection.
Journal: HIV clinical trials
Published: December 07, 2017
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.
Journal: The lancet. HIV
Published: August 31, 2017
Fatal Relapse of Myelodysplastic Syndrome in a Patient with HIV/Hepatitis C Coinfection Treated with Simeprevir/Sofosbuvir.
Journal: Journal of the International Association of Providers of AIDS Care
Published: January 17, 2017
Fecal Transplantation for Clostridium Difficile-"All Stool May Not Be Created Equal".
Journal: Journal of the International Association of Providers of AIDS Care
Published: January 30, 2016
Last Updated: 09/26/2026